Skip to main content

Table 1 Clinical characteristics of the studied women

From: Surface antigen expression on peripheral blood monocytes in women with gynecologic malignancies

Clinical Data

Endometrial Cancer

Cervical Cancer

Ovarian Cancer

Group I

Group II

 

(N = 42)

(N = 13)

(N = 14)

(N = 20)

(N = 23)

Age (years)

62.52 ± 9.81;

48.77 ± 12.94;

53.21 ± 6.68;

53.42 ± 14.51;

42.52 ± 9.18;

61.50 ***

49.00

54.00 ***

51.50 **

45.00

(44–83)

(27–66)

(40–65)

(24–78)

(25–59)

Gravidity

2.88 ± 2.20;

1.54 ± 1.33;

2.79 ± 2.04;

2.10 ± 2.40;

Insufficient data

2.50;

1.00;

2.50;

2.00;

(0–13)

(0–5)

(0–8)

(0–10)

Parity

2.69 ± 1.96;

1.15 ± 0.90;

2.57 ± 1.74;

1.85 ± 2.06;

Insufficient data

2.00;

1.00;

2.00;

2.00;

(0–12)

(0–3)

(0–7)

(0–8)

Body mass (kg)

87.13 ± 20.56;

62.46 ± 11.21;

65.09 ± 10.21;

71.30 ± 17.34;

Insufficient data

85.00

60.00

69.00

68.50

(45–130)

(46–80)

(48–78)

(47–120)

Height (cm)

159.68 ± 6.73;

160.54 ± 5.56;

161.43 ± 4.29;

164.35 ± 5.11;

Insufficient data

160.00

162.00

160.00

164.00

(135–172)

(152–172)

(157–170)

(156–174)

BMI (kg • (m2)-1)

34.14 ± 7.82;

24.38 ± 4.99;

24.97 ± 3.81;

26.37 ± 6.20;

Insufficient data

31.94

22.77

26.43

24.86

(20.31-50.78)

(15.55-33.73)

(18.28-28.92)

(18.83-4.62)

Percentage of subjects after menopause (%)

90.48 ***

46.15

71.43 **

60.00 *

26.09

  1. Group I - women operated but had no malignancy in postoperative histopathologic examination, Group II - healthy women. BMI - Body Mass Index. Data are shown as: mean ± 1 SD, median (minimum-maximum). Asterisks indicate statistically significant differences in Mann–Whitney U test: * - p < 0.05; ** - p < 0.01; *** - p < 0.001, in comparison to Group II.